Frontiers | Utility of Clinical–Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions
Diagnostics | Free Full-Text | Impact of Chronic Prostatitis on the PI-RADS Score 3: Proposal for the Addition of a Novel Binary Suffix
Prostate Imaging-Reporting and Data System (PI-RADS) | Radiology Reference Article | Radiopaedia.org
PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer? - ScienceDirect
Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions. | Semantic Scholar
The basics of PI-RADS scoring and how AI can help
The role of the Contrast Series in Prostate MRI
Diagnostic performance of PI-RADS version 2.1 compared to version 2.0 for detection of peripheral and transition zone prostate cancer | Scientific Reports
Comparison of Multiparametric MRI Scoring Systems and the Impact on Cancer Detection in Patients Undergoing MR US Fusion Guided Prostate Biopsies | PLOS ONE
RadioGraphics Update: PI-RADS Version 2.1—A Pictorial Update | RadioGraphics
Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions | Scientific Reports
MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? - Schoots - Translational Andrology and Urology
The Role of PSA Density among PI-RADS v2.1 Categories to Avoid an Unnecessary Transition Zone Biopsy in Patients with PSA 4-20 ng/mL
PI-RADS Version 2: A Pictorial Update | RadioGraphics
The basics of PI-RADS scoring and how AI can help
The Radiology Assistant : Prostate Cancer - PI-RADS v2
PI-RADS 3 Lesions: Does the Association of the Lesion Volume with the Prostate-Specific Antigen Density Matter in the Diagnosis of Clinically Significant Prostate Cancer? - Beyond the Abstract
Prostate MRI based on PI-RADS version 2: how we review and report | Cancer Imaging | Full Text